Describing themselves as translating the pattern-recognition power of the immune system, the founders of Atom Bioworks have developed a system designed to make accessible nano-pattern recognition. Desiginated PEST, the platform enables sensing and therapeutics platform to help support early diagnosis and treatment for infectious diseases. The company's platform uses computational biology, software and machine learning to capture the diseased surface protein patterns and creates corresponding pattern matching constructs, enabling researchers to have access to nano-pattern recognition ability. An early application of the system - funded by NSF - involved design a rapid diagnostic for COVID-19
